Recursion Pharmaceuticals Inc (RXRX) Insider Trading
- $2,787,850.00
- $33,247,454.10
- Aug. 18, 2025
- Blake Borgeson
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 4, 2022 | CEO | 31,830 | $6.49 | Sell | $206,576.70 | |
| April 28, 2022 | CEO | 37,605 | $6.09 | Sell | $229,014.45 | |
| April 21, 2022 | CEO | 37,155 | $6.31 | Sell | $234,448.05 | |
| April 18, 2022 | CEO | 35,836 | $6.84 | Sell | $245,118.24 | |
| April 14, 2022 | CEO | 34,517 | $7.56 | Sell | $260,948.52 | |
| April 7, 2022 | CEO | 36,718 | $6.54 | Sell | $240,135.72 | |
| April 5, 2022 | CEO | 34,472 | $7.43 | Sell | $256,126.96 | |
| March 14, 2022 | CEO | 230,000 | $6.28 | Sell | $1,444,400.00 | |
| March 11, 2022 | CEO | 100,000 | $6.95 | Sell | $695,000.00 | |
| March 7, 2022 | CEO | 300,000 | $7.30 | Sell | $2,190,000.00 | |
| Feb. 22, 2022 | CEO | 100,000 | $10.22 | Sell | $1,022,000.00 | |
| Jan. 31, 2022 | CEO | 19,858 | $11.73 | Sell | $232,934.34 | |
| Jan. 13, 2022 | CEO | 87,000 | $14.33 | Sell | $1,246,710.00 | |
| Jan. 4, 2022 | Director | 9,625 | $18.03 | Sell | $173,538.75 | |
| Dec. 21, 2021 | Director | 9,625 | $18.75 | Sell | $180,468.75 | |
| Dec. 16, 2021 | COO | 2,500 | $18.74 | Sell | $46,850.00 | |
| Dec. 16, 2021 | CEO | 200 | $20.00 | Sell | $4,000.00 | |
| Dec. 13, 2021 | CEO | 100 | $20.02 | Sell | $2,002.00 | |
| Dec. 9, 2021 | CEO | 1,086 | $20.01 | Sell | $21,730.86 | |
| Dec. 7, 2021 | CEO | 3,125 | $20.51 | Sell | $64,093.75 | |
| Dec. 7, 2021 | Director | 9,625 | $20.32 | Sell | $195,580.00 | |
| Nov. 19, 2021 | Director | 13,474 | $20.20 | Sell | $272,174.80 | |
| Nov. 18, 2021 | COO | 2,500 | $18.92 | Sell | $47,300.00 | |
| Nov. 17, 2021 | Director | 5,626 | $20.04 | Sell | $112,745.04 |
Insiders are both buying and selling Recursion Pharmaceuticals Inc stock.
The insider traders at Recursion Pharmaceuticals Inc are: Blake Borgeson, Christopher Gibson, Tina Marriott Larson, Michael Secora, Shafique Virani, Tina Marriott, Mubadala Investment Co Pjsc, Dean Y Li, Gibson Christopher, Zavain Dar, Najat Khan, and Terry-Ann Burrell
The most active insider trader at Recursion Pharmaceuticals Inc is Blake Borgeson with 53 trades.
Christopher Gibson has sold the most Recursion Pharmaceuticals Inc stock with a total value of $18,575,217.95.
Mubadala Investment Co Pjsc has bought the most Recursion Pharmaceuticals Inc stock with a total value of $3,191,575.00.
The most recent insider trade for Recursion Pharmaceuticals Inc was on Aug. 18, 2025.
The single biggest insider buy for Recursion Pharmaceuticals Inc was from Mubadala Investment Co Pjsc with a total value of $730,795.32 on Feb. 21, 2023.
The single biggest insider sell for Recursion Pharmaceuticals Inc was from Christopher Gibson with a total value of $2,190,000.00 on March 7, 2022.